Targeting Pancreatic Cancer Cells and Stellate Cells Using Designer Nanotherapeutics in vitro

INTRODUCTION AND OBJECTIVE: Pancreatic cancer (PC) is characterized by a robust desmoplastic environment, which limits the uptake of the standard first-line chemotherapeutic drug gemcitabine. Enhancing gemcitabine delivery to the complex tumor microenvironment (TME) is a major clinical challenge. Mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Elechalawar, Chandra Kumar, Hossen, Md Nazir, Shankarappa, Priya, Peer, Cody J, Figg, William D, Robertson, J David, Bhattacharya, Resham, Mukherjee, Priyabrata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025663/
https://www.ncbi.nlm.nih.gov/pubmed/32103952
http://dx.doi.org/10.2147/IJN.S234112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025663/
https://www.ncbi.nlm.nih.gov/pubmed/32103952
http://dx.doi.org/10.2147/IJN.S234112

Ejemplares similares